1. Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification.
   Bob Meeusen et al, 2018, Int J Biochem Cell Biol CrossRef
2. Advances in Pathobiology of Primary Central Nervous System Lymphoma
   Xue-Liang Yang et al, 2017, Chinese Medical Journal CrossRef
3. Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma
   Binu K. Sasi et al, 2019, Leukemia CrossRef
4. null
   Carmen V. Ferreira-Halder et al, 2019 CrossRef
5. Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature
   Chakrabhavi Dhananjaya Mohan et al, 2020, Seminars in Cancer Biology CrossRef
6. Immunosuppressive receptor LILRB1 acts as a potential regulator in hepatocellular carcinoma by integrating with SHP1
   Jianghong Cheng et al, 2020, CBM CrossRef
7. Shp1 in Solid Cancers and Their Therapy
   Alessia Varone et al, 2020, Front. Oncol. CrossRef
8. Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
   Elisa Pardella et al, 2020, Cancers CrossRef
9. null
   Colin L. Welsh et al, 2021 CrossRef
10. null
    Colin L. Welsh et al, 2023 CrossRef
11. Global and promoter specific hypermethylation of tumor suppressor genes P16, SOCS1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis
    Shweta Ukey et al, 2023 CrossRef